- Home
- DERM vs COYA Comparison
DERM vs COYA Comparison
Compare DERM & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- COYA
- Stock Information
- Founded
- DERM 2014
- COYA 2020
- Country
- DERM United States
- COYA United States
- Employees
- DERM N/A
- COYA N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- DERM Health Care
- COYA Health Care
- Exchange
- DERM Nasdaq
- COYA Nasdaq
- Market Cap
- DERM 107.0M
- COYA 104.3M
- IPO Year
- DERM 2021
- COYA 2022
- Fundamental
- Price
- DERM $5.20
- COYA $6.08
- Analyst Decision
- DERM Strong Buy
- COYA Strong Buy
- Analyst Count
- DERM 3
- COYA 3
- Target Price
- DERM $9.50
- COYA $16.67
- AVG Volume (30 Days)
- DERM 145.7K
- COYA 142.0K
- Earning Date
- DERM 11-12-2024
- COYA 11-06-2024
- Dividend Yield
- DERM N/A
- COYA N/A
- EPS Growth
- DERM N/A
- COYA N/A
- EPS
- DERM N/A
- COYA N/A
- Revenue
- DERM $57,771,000.00
- COYA $9,554,315.00
- Revenue This Year
- DERM N/A
- COYA N/A
- Revenue Next Year
- DERM $37.38
- COYA $54.20
- P/E Ratio
- DERM N/A
- COYA N/A
- Revenue Growth
- DERM N/A
- COYA N/A
- 52 Week Low
- DERM $2.85
- COYA $4.75
- 52 Week High
- DERM $8.11
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- DERM 43.96
- COYA 38.00
- Support Level
- DERM $5.00
- COYA $5.90
- Resistance Level
- DERM $5.60
- COYA $7.50
- Average True Range (ATR)
- DERM 0.45
- COYA 0.50
- MACD
- DERM -0.04
- COYA -0.17
- Stochastic Oscillator
- DERM 14.98
- COYA 10.91
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.